Keylika

Keylika is an early stage biopharma startup developing metal-based drugs using a platform synthesis technology to treat unmet medical needs. We then administer these drugs using proven delivery technologies to effect the best clinical outcomes. Our first product is a small molecule iron drug (new molecular entity) delivered by a wearable skin patch to treat Iron Deficiency Anemia (IDA), with significantly higher safety, efficacy and tolerability over existing treatments. This is poised to be a best-in-class, potentially breakthrough therapy for treating iron deficiency without any GI side-effects (eg. nausea, constipation, diarrhea, etc.) typically associated with oral iron supplements, and without the risks, costs and side-effects associated with IV iron infusions. When approved, Keylika’s proprietary transdermal iron will be the world's first prescription iron patch. Iron deficiency is a hugely understated problem affecting about 1.6 billion people worldwide and more than 30 million in the US alone, translating to a $17B US market.

Website

keylika.com

City

San Francisco

Country

United States

YC batch

Summer 2022

Team

1 people

Stage

Early stage

AI-native

No

See it on the San Francisco mapSource Spot something wrong?

Claim this profile

Free and instant: prove you run keylika.com and edit the profile yourself.

• Your logo, office address and founder photos
• The ✓ Verified mark next to Keylika across the site
• Open roles listed on the Hiring board
• A followed link back to your website

A rank card with Keylika's standing on Labspie, or a simple badge. Both link to this profile and update themselves.

Rank cardBadge

DarkLight

<a href="https://labspie.com/c/keylika" title="Keylika is listed on Labspie"><img src="https://labspie.com/card/keylika-dark.svg" alt="Keylika is listed on Labspie" width="400" height="88"></a>

Copy embed code